Aniracetam

Short Description:

Aniracetam is a nootropic supplement or smart drug which was developed in the 1970′s. This compound is part of a class of nootropics known as Racetams, which are noted for their ability to promote cognitive function and increase cholinergic neurotransmission. Aniracetam also exhibits an anxiolytic effect (meaning that it reduces feelings of anxiety) and is purported to enhance mood alongside memory and focus.
Aniracetam is a synthetic compound, one of the hydroxyphenyl lacetamide heterocyclic compounds, belonging to brain function enhancers and neuroprotective agents. It acts on parts of brain cells (neurons) called AMPA receptors.

FOB Price: US 5 - 2000 / KG

Min.Order Quantity: 1 KG

Supply Ability: 10000 KG/per Month

Port: Shanghai /Beijing

Payment Terms: L/C,D/A,D/P,T/T,O/A

Shipping Terms: By sea/By Air/By Courier

Send email to us Download as PDF

Product Detail

Product Tags

Aniracetam: Cognitive Enhancer for Brain Health and Research

Product Overview
Aniracetam is a nootropic compound belonging to the racetam class, originally developed in the 1970s for cognitive enhancement. It is widely used to support memory, learning, and neuroprotection, with emerging research suggesting potential benefits in Alzheimer’s disease (AD) prevention by reducing amyloid-beta (Aβ) plaque accumulation . Available as capsules or powder, it is formulated for research and dietary supplementation (not FDA-approved for medical use in the U.S.) .

Key Features

Mechanism of Action
- AMPA Receptor Modulation: Enhances synaptic plasticity by slowing AMPA receptor desensitization, improving excitatory neurotransmission .
- BDNF Activation: Increases brain-derived neurotrophic factor (BDNF), promoting neurogenesis and synaptogenesis .
- Neuroprotection: Reduces oxidative stress and inflammation linked to Aβ toxicity, potentially delaying AD progression .
Indications
- Cognitive enhancement in healthy individuals (memory, focus, learning).
- Research applications for neurodegenerative diseases (e.g., Alzheimer’s, dementia) .
- Mood support (anxiety reduction, emotional well-being) .

Product Specifications

CAS No.: 72432-10-1 | Purity: ≥98% (HPLC)
Molecular Formula: C₁₂H₁₃NO₃ | Molecular Weight: 219.24 g/mol
Form: White crystalline powder or capsules.
Storage: -20°C in airtight containers; stable for ≥5 years .

Available Sizes

1g: 618.00∣5g:2136.00 (pre-order) .

Usage Guidelines

Dosage: 500–1500 mg/day, divided into 2–3 doses. Take with fatty foods (e.g., olive oil) to enhance bioavailability .
Duration: Effects onset within 10–30 minutes, lasting 4–6 hours .
Combination Therapy: Pair with cholinergics (e.g., Alpha-GPC) to optimize cognitive effects .

Safety & Side Effects

Common Side Effects: Mild anxiety, insomnia, headache, or gastrointestinal discomfort. Most symptoms resolve with continued use .
Contraindications: Avoid during pregnancy or lactation (suspected reproductive toxicity) .
Precautions: Consult a healthcare provider before use, especially with pre-existing conditions or medications .

Research Highlights

Alzheimer’s Disease: Aniracetam may reduce Aβ production by upregulating α-secretase activity via BDNF and mGluR pathways .
Clinical Trials: Demonstrated safety and tolerability in elderly populations over 6-month periods .

Regulatory & Compliance

Intended Use: For research purposes only. Not for human consumption or diagnostic/therapeutic applications .
Legal Status: Available as a dietary supplement in the U.S.; prescription-only in Europe .

References